Digital neurologic assessment: An AI solution for development of remote cranial nerve examination
Summary
We need new tools to find and track brain diseases better, as people get older. Technology has improved, but it's still hard to examine small parts of the face and mouth, like the tongue. This project wants to fix that by making a way to follow how the tongue works during tests for brain health. We will use audio and video recordings from a computer to create accurate ways to track tongues. We will check these against existing tests to make sure they work well. The goal is to make a tool that doctors everywhere can use during tests. This could change how we check brain health by letting us track it automatically and from far away. It might help patients with brain problems get better results.
Eligibility
Eligible ages: 45 to 80
Accepts healthy participants: Yes
Inclusion criteria:
Requirements for participation for patients are:
1. Diagnosis of amyotrophic lateral sclerosis (ALS) or primary lateral sclerosis (PLS).
2. Age 45 years or older.
3. Access to a desktop computer/laptop with a microphone and webcam
4. Access to a stable internet connection capable of at least 5 MBPS
Requirements for control participants are:
1. Normal/adequate hearing and vision
2. Negative history of disorders beyond those under consideration
3. Normal depression and cognitive scores
4. Fluency in English
5. Access to a desktop computer/laptop with a microphone and webcam
6. Access to a stable internet connection capable of at least 5 MBPS
Exclusion criteria:
1. Non-ALS medical condition that significantly interferes with mobility.
Participate
Fill out the following form if you want to participate in this research
Collection of personal information
Your personal information is collected under
the authority of section 33(c) of the Freedom of Information and Protection of Privacy Act. If
you have any questions about the collection or use of this information, please visit our
Access to Information page.
Additional information
Contact information
Dr. Gordon Jewett
Principal investigator:
Gordon Jewett
Clinical trial:
No
REB-ID:
REB24-1382